Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A safety and feasibility study of the use of 670 nm red light in premature neonates

Abstract

Objective:

Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina affecting extremely preterm or low birth weight infants The aim of this study was to assess the feasibility and safety of 670 nm red light use in a neonatal intensive care unit.

Study Design:

Neonates <30 weeks gestation and <1150 g were enrolled within 48 h of birth. Data collected included cause of preterm delivery, Apgar scores and birthweight. 670 nm red light was administered for 15 min per day from a distance of 25 cm, delivering 9 J cm2, from the time of inclusion in the study until 34 weeks postmenstrual age. Infants were assessed daily for the presence of any skin burns or other adverse signs.

Result:

Twenty-eight neonates were enrolled, seven 24 to 26 weeks and twenty-one 27 to 29 weeks gestation. The most common cause for preterm delivery was preterm labor (14/28) with five of these having evidence of chorioamnionitis. There were no skin burns or other documented adverse events. Entry into the study was readily achieved and treatment was well accepted by parents and nursing staff.

Conclusion:

670 nm red light appears to be a safe and feasible treatment for further research in respect to ROP.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Austeng D, Kallen KBM, Hellstrom A, Tornqvist K, Holmstrom GE . Natural history of retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden. Arch Ophthalmol 2010; 128: 1289–1294.

    Article  Google Scholar 

  2. Haddad MAO, Sei M, Sampaio MW, Kara-Jose N . Causes of visual impairment in children: a study of 3210 cases. J Pediatr Ophthalmol Strabismus 2007; 44: 232–240.

    PubMed  Google Scholar 

  3. Larsson EK, Rydberg AC, Holstrom GE . A population-based study on the visual outcome in 10 year-old preterm and full-term children. Arch Ophthalmol 2005; 123: 825–832.

    Article  Google Scholar 

  4. Larsson E, Martin L, Holmstrom GE . Peripheral and central visual fields in 11-year old children who had been born prematurely and at term. J Pediatr Ophthalmol Strabismus 2004; 41: 39–45.

    Article  Google Scholar 

  5. Larsson E, Rydberg A, Holmstrom GE . Contrast sensitivity in 10 year old preterm and full term children: a population based study. Br J Ophthalmol 2006; 90: 87–90.

    Article  CAS  Google Scholar 

  6. Larsson EK, Rydberg AC, Holmstrom GE . A population-based study of the refractive outcome in 10-year-old preterm and full-term children. Arch Ophthalmol 2003; 121: 430–436.

    Article  Google Scholar 

  7. O’Connor AR, Stephenson TJ, Johnson A, Tobin MJ, Ratib S, Fielder AR et al. Strabismus in children of birth weight less than 1701 g. Arch Ophthalmol 2002; 120: 767–773.

    Article  Google Scholar 

  8. Good WV . Final results of the early treatment for retinopathy of prematurity (ETROP) randomizes trial. Trans Am Ophthalmol Soc 2004; 102: 233–250.

    PubMed  PubMed Central  Google Scholar 

  9. Dobson V, Quinn GE, Summers CG, Saunders RA, Phelps DL, Tung B et al. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant. Invest Ophthalmol Vis Sci 1994; 35: 4236–4244.

    CAS  PubMed  Google Scholar 

  10. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity. Arch Ophthalmol 2001; 119: 1129–1133.

    Article  Google Scholar 

  11. Repka MX, Summers CG, Palmer EA, Dobson V, Tung B, Davis B et al. The incidence of ophthalmologic interventions in children with birth weights less than 1251 grams. Results through 5 ½ years. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1998; 105: 1621–1627.

    Article  CAS  Google Scholar 

  12. Section on Ophthalmology, American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006; 117: 572–576.

    Article  Google Scholar 

  13. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for treatment of retinopathy or prematurity: results of the Early Treatment for Retinopathy of Prematurity Randomized Trial. Arch Ophthalmol 2003; 121: 1684–1696.

    Article  Google Scholar 

  14. Askie LM, Brocklehurst P, Darlow BA, Finer N, Schimdt B Tarnow-Mordi W on behalf of the NeOProM Collaborative Group. NeOProM: Neonatal oxygenation prospective meta-analysis collaboration study. BMC Pediatr 2011; 11: 6.

    Article  Google Scholar 

  15. Eells JT, Wong-Riley MT, VerHoeve J, Henry M, Buchman EV, Kane MP et al. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion 2004; 4 (5-6): 559–567.

    Article  CAS  Google Scholar 

  16. Eells JT, Henry MM, Summerfelt P, Wong-Riley MT, Buchmann EV, Kane M et al. Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad Sci USA 2003; 100: 3439–3444.

    Article  CAS  Google Scholar 

  17. Kirk DK, Gopalakrishnan S, Schmitt H, Abroe B, Stoehr M, Duibs A et al. Photobiomodulation reduces photoreceptor death and regulates cytoprotection in early stages of P23H retinal dystrophy. Proceedings of SPIE. SPIE Digital Library, USA, 2013 8569, 85690F-1. http://proceedings.spiedigitallibrary.org/volume.aspx?volumeid=15800 (last accessed 18th June 2014).

  18. Albarracin R, Eells J, Valter K . Photobiomodulation protects the retina from light-induced photoreceptor degeneration. Invest Ophthalmol Vis Sci 2011; 52: 3582–3592.

    Article  Google Scholar 

  19. Albarracin R, Valter K . Treatment with 670-nm light protects the cone photoreceptors from white light-induced degeneration. Adv Exp Med Biol 2012; 723: 121–128.

    Article  CAS  Google Scholar 

  20. Albarracin R, Valter K . 670 nm red light preconditioning supports Muller cell function: evidence from the white light-induced damage model in the rat retina. Photochem Photobiol 2012; 88: 1418–1427.

    Article  CAS  Google Scholar 

  21. Qu C, Cao W, Fan Y, Lin Y . Near-infrared light protects the photoreceptor from light-induced damage in rats. Adv Exp Med Biol 2010; 664: 365–374.

    Article  Google Scholar 

  22. Eells J, DeSmet K, Kirk D, Wong-Riley M, Whelan H, Ver Hoeve J et al. Photobiomodulation for the treatment of retinal injury and retinal degenerative diseases. Waynant R, Tata D (eds). Proceedings of II Light Activated Tissue Regeneration and Therapy Conference. Springer, USA, 2008; 12: 39–51.

    Chapter  Google Scholar 

  23. Purushothuman S, Johnstone DM, Nandasena C, Mitrofanis J, Stone J . Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from transgenic mouse models. Alzheimer’s Res Ther 2014; 6: 2.

    Article  Google Scholar 

  24. Peoples C, Spana S, Ashkan K, Benabid A, Stone J, Baker G et al. Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson’s disease. Parkinsonism Relat Disord 2013; 18: 469–476.

    Article  Google Scholar 

  25. Purushothuman S, Johnstone DM, Stone J, Mitrofanis J . The impact of near-infrared light on dopaminergic cell survival in a transgenic mouse model of Parkinsonism. Brain Res 2013; 1535: 61–70.

    Article  CAS  Google Scholar 

  26. Oron A, Oron U, Chen J, Eilam A, Zhang C, Sadeh M et al. Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke 2006; 37: 2620–2624.

    Article  Google Scholar 

  27. Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B et al. Infrared laser therapy for ischemic stroke: a new treatment strategy. Results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke 2007; 38: 1843–1849.

    Article  Google Scholar 

  28. Liang HL, Whelan HT, Eells JT, Meng H, Buchmann E, Lerch-Gaggl A et al. Photobiomodulation partially rescues visual cortical neurons from cyanide-induced apoptosis. Neuroscience 2006; 139: 639–649.

    Article  CAS  Google Scholar 

  29. Natoli R, Valter K, Barbosa M, Dahlstrom JE, Rutar M, Kent AL et al. 670 nm photobiomodulation as a novel protection against retinopathy of prematurity: evidence from oxygen induced retinopathy models. PLoS ONE 2013; 8: e72135.

    Article  CAS  Google Scholar 

  30. Chow SW, For the Australian and New Zealand Neonatal Network Executive. 2011 Report of the Australian and New Zealand Neonatal Network http://www.npesu.unsw.edu.au/sites/default/files/npesu/surveillances/Report%20of%20the%20Australian%20and%20New%20Zealand%20Neonatal%20Network%202011.pdf (Last accessed 20 May 2014).

  31. Dobson V, Quinn GE, Saunders RA, Spencer R, Davis BR, Risser J et al. Grating visual acuity in eyes with retinal residua of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1995; 113: 1172–1177.

    Article  CAS  Google Scholar 

  32. Quinn GE, Dobson V, Kivlin J, Kaufman LM, Repka MX, Reynolds JD et al. Prevalence of myopia between 3 months and 5 ½ years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1998; 105: 1292–1230.

    Article  CAS  Google Scholar 

  33. Ciner EB, Ying GS, Kulp MT, Maguire MG, Quinn GE, Orel-Bixler D et alVision in Preschoolers Study Group. Stereoacuity of preschool children with and without vision disorders. Optom Vis Sci 2014; 91: 351–358.

    Article  Google Scholar 

  34. The Vision in Preschoolers Study Group. Sensitivity of screening tests for detecting vision in preschoolers-targeted vision disorders when specificity is 94%. Optom Vis Sci 2005; 82: 432–438.

    Article  Google Scholar 

  35. Fitzgerald M, Hodgetts S, Van den Heuvel C, Natoli R, Hart NS, Valter K et al. Red/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders. Rev Neurosci 2013; 24: 205–226.

    Article  Google Scholar 

  36. Mitchell UH, Mack GL . Low-level laser treatment with near-infrared light increases venous nitric oxide levels acutely: a single-blind, randomized clinical trial of efficacy. Am J Phys Med Rehabil 2013; 92: 151–156.

    Article  Google Scholar 

  37. AI Rashoud AS, Abboud RJ, Wang W, Wigderowitz C . Efficacy of low-level laser therapy applied at acupuncture points in knee osteoarthritis: a randomised double-blind comparative trial. Physiotherapy 2013; 100: 242–248.

    Article  Google Scholar 

  38. Kajagar BM, Godhi AS, Pandit A, Khatri S . Efficacy of low level laser therapy on wound healing in patients with chronic diabetic foot ulcers – a randomised control trial. Indian J Surg 2012; 74: 359–363.

    Article  Google Scholar 

  39. Diabetic Macular Edema Near Infrared Treatment Trial. http://www.nyee.edu/ctoph-diabetic-macular-edema-near-infrared-treatment-trial.html (last accessed 17 June 2014).

  40. Toronto and Oak Ridges Photobiomodulation (PBM) study for Dry Age Related Macular Degeneration. http://www.photospectra.ca/uploads/FINAL_TORPA%20RESULTS.pdf (last accessed 17 June 2014).

Download references

Acknowledgements

This study was supported by a grant from the Canberra Hospital Private Practice Fund.

Author Contributions

MB, MB, RE, MEA, JD, KV, JP and RN conceived and designed the study; AK, MB, VP and MEA performed the study; AK analyzed the data; AK, MB, RE, MEA, JD, KV, JP and RN wrote the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A L Kent.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kent, A., Broom, M., Parr, V. et al. A safety and feasibility study of the use of 670 nm red light in premature neonates. J Perinatol 35, 493–496 (2015). https://doi.org/10.1038/jp.2015.5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2015.5

This article is cited by

Search

Quick links